INRLF
Price
$3.50
Change
+$0.34 (+10.76%)
Updated
Mar 25 closing price
Capitalization
566.58M
VALN
Price
$7.00
Change
+$0.09 (+1.30%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
566.58M
33 days until earnings call
Ad is loading...

INRLF vs VALN

Header iconINRLF vs VALN Comparison
Open Charts INRLF vs VALNBanner chart's image
Valneva SE
Price$3.50
Change+$0.34 (+10.76%)
Volume$1K
Capitalization566.58M
Valneva SE
Price$7.00
Change+$0.09 (+1.30%)
Volume$988
Capitalization566.58M
INRLF vs VALN Comparison Chart
Loading...
VALN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INRLF vs. VALN commentary
Apr 04, 2025

To understand the difference between Valneva SE (INRLF) vs. Valneva SE - ADR (VALN) it is enough to know the definitions of ADR

ADR - American depositary receipt (ADR) is a certificate issued by a U.S. depositary bank representing a specified number of shares (often 1 share) of a foreign company's stock. ADRs are denominated in U.S. dollars and trade on U.S. stock markets and OTC depending on the ADRs classification.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (INRLF: $3.45 vs. VALN: $6.97)
Brand notoriety: INRLF and VALN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INRLF: 15% vs. VALN: 97%
Market capitalization -- INRLF: $566.58M vs. VALN: $566.58M
INRLF [@Biotechnology] is valued at $566.58M. VALN’s [@Biotechnology] market capitalization is $566.58M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INRLF’s FA Score shows that 0 FA rating(s) are green whileVALN’s FA Score has 1 green FA rating(s).

  • INRLF’s FA Score: 0 green, 5 red.
  • VALN’s FA Score: 1 green, 4 red.
According to our system of comparison, VALN is a better buy in the long-term than INRLF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VALN’s TA Score shows that 4 TA indicator(s) are bullish.

  • VALN’s TA Score: 4 bullish, 2 bearish.

Price Growth

INRLF (@Biotechnology) experienced а -1.43% price change this week, while VALN (@Biotechnology) price change was -3.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

VALN is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INRLF($567M) and VALN($567M) have the same market capitalization . INRLF YTD gains are higher at: 67.464 vs. VALN (59.424). INRLF (21.2M) and VALN (21.2M) have comparable annual earnings (EBITDA) . INRLF (156M) and VALN (156M) have equal amount of cash in the bank . INRLF (201M) and VALN (201M) have identical debt. INRLF (159M) and VALN (159M) have equivalent revenues.
INRLFVALNINRLF / VALN
Capitalization567M567M100%
EBITDA21.2M21.2M100%
Gain YTD67.46459.424114%
P/E RatioN/AN/A-
Revenue159M159M100%
Total Cash156M156M100%
Total Debt201M201M100%
FUNDAMENTALS RATINGS
INRLF: Fundamental Ratings
INRLF
OUTLOOK RATING
1..100
31
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
74
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
VALN
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 16 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
VALN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TDFCX7.97N/A
N/A
Transamerica Sustainable Equity Inc C
ANPRX28.68N/A
N/A
Virtus NFJ Mid-Cap Value R6
FFDKX88.55N/A
N/A
Fidelity K
GAGVX21.06N/A
N/A
Goldman Sachs U.S. Equity ESG A
LOGWX25.36N/A
N/A
Lord Abbett Developing Growth F3

INRLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, INRLF has been loosely correlated with VALN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if INRLF jumps, then VALN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INRLF
1D Price
Change %
INRLF100%
N/A
VALN - INRLF
42%
Loosely correlated
+2.36%
IKT - INRLF
22%
Poorly correlated
+4.31%
IMMX - INRLF
21%
Poorly correlated
+2.48%
NBTX - INRLF
20%
Poorly correlated
-5.03%
VXRT - INRLF
20%
Poorly correlated
-6.04%
More

VALN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VALN has been loosely correlated with INRLF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VALN jumps, then INRLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VALN
1D Price
Change %
VALN100%
+0.73%
INRLF - VALN
42%
Loosely correlated
-1.43%
PTCT - VALN
32%
Poorly correlated
-3.35%
IPHA - VALN
32%
Poorly correlated
+7.26%
ORMP - VALN
32%
Poorly correlated
-2.27%
VERA - VALN
28%
Poorly correlated
-3.52%
More